published meta-analysis   sensitivity analysis   studies

Ibuprofen in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsRinott, 2020 1.22 [0.32; 4.60] 1.22[0.32; 4.60]Rinott, 202010%403NAnot evaluable mechanical ventilationdetailed resultsRinott, 2020 0.93 [0.43; 2.01] 0.93[0.43; 2.01]Rinott, 202010%403NAnot evaluable ICU admissiondetailed resultsRinott, 2020 1.42 [0.49; 4.10] 1.42[0.49; 4.10]Rinott, 202010%403NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-06-14 09:11 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 752 - roots T: 290